MANCHIKANTI KRISHNAMURTHY: Biological laser plasma x-ray point source. TATA INSTITUTE OF FUNDAMENTAL RESEARCH, Majumdar Subhatosh, May 12, 2011: WO/2011/055376 (47 worldwide citation)

The invention provides targets coated with structured biological materials, which are employed in laser produced plasma systems. The biological materials selected from cells of microbial, protozoan or plankton origin are applied on a portion of a solid target, like polished glass plate which then fo ...

BOJARSKI RAYMOND A: Patient-adapted and improved orthopedic implants, designs and related tools. CONFORMIS, Sunstein Bruce D, May 12, 2011: WO/2011/056995 (40 worldwide citation)

Methods and devices are disclosed to create models, implants, and related tools and procedures based on data derived from the existing joint. The data can be used to create model that can be used to analyze the patient's joint and to devise and evaluate a course of corrective action. The data also c ...

CHUNG CHUN WA: Bromodomain inhibitors for treating autoimmune and inflammatory diseases. GLAXOSMITHKLINE, SHORE ANDREW DAVID, May 12, 2011: WO/2011/054843 (35 worldwide citation)

The use of a bromodomain inhibitor in the treatment of autoimmune and inflammatory diseases or conditions, pharmaceutical compositions containing such compounds and to methods for identifying compounds for use in the treatment of such diseases or conditions.

WILLEMS FRANK: Non-woven fabric for medical use and process for the preparation thereof. NONWOTECC MEDICAL, Von Kreisler Selting Werner, May 12, 2011: WO/2011/054932 (34 worldwide citation)

Process for preparing a non-woven fabric for medical use, comprising the following steps: -performing a spraying process in which -a spray jet is generated from a polycarbonate urethane plastic solution having a viscosity of from 800 to 1500 Pa×s using a spraying unit from which the polycarbonate ur ...

VANDYCK KOEN: Benzimidazole-imidazole derivatives. TIBOTEC PHARMACEUTICALS, Daelemans Frank, May 12, 2011: WO/2011/054834 (25 worldwide citation)

Inhibitors of HCV replication of formula (I) including stereochemically isomeric forms, and salts, solvates thereof, wherein R and R' are, each independently,-CR1R2R3, aryl, heteroaryl or heteroC4-6cycloalkyl, whereby aryl and heteroaryl may optionally be substituted with 1 or 2 substituents selecte ...

BOUILLOT ANNE MARIE JEANNE: Imidazo [4, 5-c] quinoline derivates as bromodomain inhibitors. GLAXOSMITHKLINE, SHORE ANDREW DAVID, May 12, 2011: WO/2011/054846 (24 worldwide citation)

Novel compounds of Formula (I) and salts thereof, pharmaceutical compositions containing such compounds and their use in therapy.

LOW PHILIP: Head harness & wireless eeg monitoring system. NEUROVIGIL, Jurgensen Thomas E, May 12, 2011: WO/2011/056679 (23 worldwide citation)

An assembly and system for collection and assessment of physiological data is provided. The assembly includes a physiological data acquisition module that may be used in combination with a head harness for the collection, recordation, storage and transmission of quality physiological data. The assem ...

ASJES RONALD JAN: Device for positioning electrodes on a users scalp. KONINKLIJKE PHILIPS ELECTRONICS, Kroeze John, May 12, 2011: WO/2011/055291 (21 worldwide citation)

A device (1) is described for positioning electrodes on a user's scalp. It comprises a housing (3), for example a headpiece of a headphones device, which can be put around a user's head. An elastic element (11) and a plurality of electrodes are positioned, so that once the housing (3) is put around ...

COHEN DANIEL: New therapeutic approaches for treating alzheimer disease. PHARNEXT, Becker Philippe, May 12, 2011: WO/2011/054759 (21 worldwide citation)

The present invention relates to compositions and methods for the treatment of Alzheimer's disease and related disorders. More specifically, the present invention relates to novel combinatorial therapies of Alzheimer's disease and related disorders. In particular, the invention concerns compounds wh ...

Sorensen Alexandra Mp Santana: Treatment of infections with tp receptor antagonists. EVOLVA, Miao Emily, May 12, 2011: WO/2011/057262 (19 worldwide citation)

The present invention relates to TP Receptor Antagonists for treatment of infection, Prodrugs and salts of the present pharmaceutical compositions are also provided.